Work

The Role of Filgotinib in Ulcerative Colitis and Crohn’s Disease

Year: 2023

Type: review

Source: Immunotherapy

DOI: 10.2217/imt-2023-0116

Authors: Jacopo Fanizza, Ferdinando D’Amico, Gaetano Lauri, Samuel J Martinez-Dominguez, Mariangela Allocca, Federica Furfaro, Alessandra Zilli, Gionata Fiorino, Tommaso Lorenzo Parigi, Simona Radice, Laurent Peyrin-Biroulet, Silvio Danese

Institutions: Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Humanitas University, Universidad de Zaragoza, Hospital Clínico Universitario Lozano Blesa, Inserm, Centre Hospitalier Régional et Universitaire de Nancy, Nutrition-Génétique et Exposition aux Risques Environnementaux, Université de Lorraine

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, Pfizer, Biogen, AbbVie, Prometheus, Fresenius Kabi, Celltrion, Galápagos, Protagonist Therapeutics, Australian Renewable Energy Agency, Medac, Janssen Biotech, Inotrem, Samsung Bioepis, Mundipharma

OpenAlex ID: W4389058196

FWCI: 0.599

Cites: 79

Cited by: 16

Related to: 10